Study uncovers epigenetic source of resistance to targeted therapy in EGFR-mutant lung cancer
When lung cancers driven by mutations in the EGFR gene become resistant to osimertinib or other targeted therapies, epigenetic changes, rather than genetic changes, are often to blame.
Aug 3, 2023
0
6